---
title: "Gene sequencing concept stocks fluctuated and strengthened, Meinian Onehealth and Kingmed Diagnostics hit the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227461437.md"
description: "Gene sequencing concept stocks fluctuated and strengthened, Meinian Onehealth and Kingmed Diagnostics hit the daily limit, MGI rose over 10%, and BGI Genomics and Berry Genomics followed suit"
datetime: "2025-02-07T02:57:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227461437.md)
  - [en](https://longbridge.com/en/news/227461437.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227461437.md)
generator: "portal-rs"
---

# Gene sequencing concept stocks fluctuated and strengthened, Meinian Onehealth and Kingmed Diagnostics hit the daily limit

Gene sequencing concept stocks fluctuated and strengthened, Meinian Onehealth and Kingmed Diagnostics hit the daily limit, MGI rose over 10%, and BGI Genomics and Berry Genomics followed suit

### Related Stocks

- [688114.CN](https://longbridge.com/en/quote/688114.CN.md)
- [300676.CN](https://longbridge.com/en/quote/300676.CN.md)
- [000710.CN](https://longbridge.com/en/quote/000710.CN.md)
- [002044.CN](https://longbridge.com/en/quote/002044.CN.md)
- [603882.CN](https://longbridge.com/en/quote/603882.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Tennessee Fertility Institute Announces Patient Services Alliance with Vanderbilt Health](https://longbridge.com/en/news/296538486.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [Genetix kicks off sickle cell disease awareness campaign](https://longbridge.com/en/news/296468544.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**